GHK-CU research-grade peptide, third-party tested with COA available (99%+ purity)
BPC-157 and GHK-Cu both produce higher local tissue concentrations near the injection site even though they distribute systemically
Studies suggest it may reduce muscle wasting and accelerate recovery from muscle tears when administered during the acute injury phase
Potential Side Effects, Safety Profile, and Regulatory Status of BPC 157 In preclinical studies, BPC 157 caused mild local irritation at the site of administration, which was the most commonly reported side effect but did not appear to lead to long-term issues
The apparent lack of a direct effect was noted due to the in vitro environment not mimicking the inherent environment of a tendon in vivo
However, for an economic bioprocess production of GSH key factors like media costs, strain performance and process scalability are essential